U.S. antimicrobial sales for use in swine increased in 2021

© Medically important antimicrobial drugs approved for use in food-producing animals. Actively marketed in 2016-2021. Domestic sales and distribution data reported by species-specific estimated sales.

Sales of medically important antimicrobial drugs for use in swine were up 3% from 2020.

The U.S. Food and Drug Administration’s Center for Veterinary Medicine published the 2021 Summary Report on Antimicrobials Sold or Distributed for Use in Food-Producing Animals. In the U.S. sales and distribution of medically important antimicrobial drugs approved for use in food-producing animals decreased by less than one percent between 2020 and 2021. Since the significant decrease in sales volume in 2017, annual sales of medically important antimicrobials have remained at reduced levels. Compared to 2015 (peak year of sales), 2021 sales decreased 38%.

In regards to medically important antimicrobial drugs for use in swine, sales were up 3% from 2020 with a total of 2,529,800 kg (of active ingredient) however, compared to 2016 levels this is a 19% decrease.

FDA recognizes that fluctuations in sales volume may occur over time in response to various factors, including changing animal health needs or changes in animal populations. Given the substantial change that occurred with transitioning a large number of products containing medically important antimicrobials from over-the-counter use to a marketing status requiring veterinary oversight at the beginning of 2017, some rebound in the reported sales volume in subsequent years was not unexpected as affected stakeholders adjusted to the new requirements.

PigUA.info by materials pig333.com